Frontiers in Medicine最新文献

筛选
英文 中文
Obstetrical and perinatal outcomes of women with preeclampsia at Woldia Comprehensive Specialized Hospital, Northeast Ethiopia 埃塞俄比亚东北部 Woldia 综合专科医院子痫前期妇女的产科和围产期结果
IF 3.9 3区 医学
Frontiers in Medicine Pub Date : 2024-09-18 DOI: 10.3389/fmed.2024.1326333
Henok Kumsa, Desalew Mergiyaw
{"title":"Obstetrical and perinatal outcomes of women with preeclampsia at Woldia Comprehensive Specialized Hospital, Northeast Ethiopia","authors":"Henok Kumsa, Desalew Mergiyaw","doi":"10.3389/fmed.2024.1326333","DOIUrl":"https://doi.org/10.3389/fmed.2024.1326333","url":null,"abstract":"BackgroundPreeclampsia is a multisystem disorder that affects pregnant women. Preeclampsia and its complications are the leading causes of maternal and perinatal morbidity and mortality in developing countries. Studies conducted in Ethiopia have primarily concentrated on preeclampsia’s trends and prevalence rather than its obstetrical and perinatal consequences. Thus, this study aimed to determine the risk of adverse obstetric and perinatal outcomes among women with preeclampsia at Woldia Comprehensive Specialized Hospital, Northeast Ethiopia.MethodsA retrospective cohort study was conducted among 140 preeclamptic women and 280 normotensive women who gave birth at Woldia Comprehensive Specialized Hospital between 30 December 2020 and 29 December 2022. Maternal records were retrieved using data-extraction tools. The data were entered into EpiData version 4.6.0.6 and analyzed using SPSS version 26. Binary and multivariable logistic regression models were used to test the associations between independent and outcome variables. The adjusted odds ratio (OR) with a 95% confidence interval (CI) and <jats:italic>p</jats:italic>-values &amp;lt;0.05 were used to measure the strength of the association and declare the level of statistical significance.ResultsThe odds of at least one adverse obstetric outcome among preeclamptic women were 2.25 times higher than those among normotensive women [AOR: 2.25, 95% CI: (1.06, 4.77)]. In addition, babies born to preeclamptic women were at a higher risk of perinatal death [AOR: 2.90, 95% CI: (1.10, 8.17)], low birth weight [AOR: 3.11, 95% CI: (1.43, 6.7)], birth asphyxia [AOR: 2.53, 95% CI: (1.15, 5.5)], and preterm birth [AOR: 2.21, 95% CI: (1.02, 4.8)] than babies born to normotensive women.ConclusionMore adverse obstetric and perinatal outcomes were observed in women with preeclampsia than those in normotensive women. This study highlights the significantly elevated level of at least one adverse obstetric outcome associated with preeclampsia, low hemoglobin level, and rural residents. Moreover, perinatal death, low birth weight, asphyxia, and preterm birth were significantly associated with preeclampsia.","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142266432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: New technological devices for dermatological application: upgrades and efficacy. 社论:皮肤科应用的新技术设备:升级与功效。
IF 3.1 3区 医学
Frontiers in Medicine Pub Date : 2024-09-18 eCollection Date: 2024-01-01 DOI: 10.3389/fmed.2024.1491435
Gislaine Ricci Leonardi, Isabel F Almeida, Marlus Chorilli
{"title":"Editorial: New technological devices for dermatological application: upgrades and efficacy.","authors":"Gislaine Ricci Leonardi, Isabel F Almeida, Marlus Chorilli","doi":"10.3389/fmed.2024.1491435","DOIUrl":"10.3389/fmed.2024.1491435","url":null,"abstract":"","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11445821/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges and opportunities in transitional care process in Behçet’s syndrome 贝赫切特综合征过渡护理过程中的挑战与机遇
IF 3.9 3区 医学
Frontiers in Medicine Pub Date : 2024-09-18 DOI: 10.3389/fmed.2024.1456063
Federica Di Cianni, Maria Vincenza Mastrolia, Edoardo Biancalana, Diana Marinello, Giacomo Emmi, Marta Mosca, Gabriele Simonini, Rosaria Talarico
{"title":"Challenges and opportunities in transitional care process in Behçet’s syndrome","authors":"Federica Di Cianni, Maria Vincenza Mastrolia, Edoardo Biancalana, Diana Marinello, Giacomo Emmi, Marta Mosca, Gabriele Simonini, Rosaria Talarico","doi":"10.3389/fmed.2024.1456063","DOIUrl":"https://doi.org/10.3389/fmed.2024.1456063","url":null,"abstract":"Behçet’s syndrome (BS) is a rare chronic multi-systemic inflammatory disorder that usually involves adults between third and fourth decades of life, while pediatric and juvenile onset are relatively rare. BS young patients (YP) often develop a full-blown disease late after onset, requiring careful diagnostic workup and regular follow-up while they grow up. In this regard, the purpose of transitional programs is to ensure continuous high-quality care to YP with chronic conditions, providing them with the skills necessary to become independent and empowered adults able to chronically self-manage their disease. EULAR/PReS released the first set of standards and recommendations for transitional care (TC) of YP with juvenile-onset rheumatic diseases, but the appropriate timing for transition, the tools to evaluate patients’ readiness, and indicators of transition plans effectiveness still need to be identified. Although little is known regarding TC in BS, it is easy to assume that BS YP will benefit from developmentally and disease-specifically appropriate transition plans, which may promote continuity of care, improve perceived quality of life and prevent poor disease outcomes. This perspective article discusses the key concepts and the goals of TC, addressing the potential challenges and opportunities of TC for YP with BS in clinical practice.","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142266394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous serratus anterior plane block for postoperative analgesia following lung transplantation via anterolateral incision: a pilot study 通过前外侧切口进行肺移植术后镇痛的连续前锯肌平面阻滞:一项试点研究
IF 3.9 3区 医学
Frontiers in Medicine Pub Date : 2024-09-18 DOI: 10.3389/fmed.2024.1438580
Ge Luo, Tingting Ni, Xinchen Tao, Jie Xiao, Yuanyuan Yao, Man Huang, Jingyu Chen, Min Yan
{"title":"Continuous serratus anterior plane block for postoperative analgesia following lung transplantation via anterolateral incision: a pilot study","authors":"Ge Luo, Tingting Ni, Xinchen Tao, Jie Xiao, Yuanyuan Yao, Man Huang, Jingyu Chen, Min Yan","doi":"10.3389/fmed.2024.1438580","DOIUrl":"https://doi.org/10.3389/fmed.2024.1438580","url":null,"abstract":"BackgroundUnilateral or bilateral anterolateral thoracotomy May lead to severe acute pain in lung transplantation (LTx). Although serratus anterior plane block (SAPB) is apparently effective for pain control after open thoracic surgery, there remains a lack of evidence for the application of SAPB for postoperative analgesia after LTx.ObjectiveIn this case series pilot study, we describe the feasibility of continuous SAPB after lung transplantation and provide a preliminary investigation of its safety and efficacy.MethodsAfter chest incisions closure was complete, all patients underwent ultrasound-guided SAPB with catheter insertion. Numerical rating scale (NRS), additional opioid consumption, time to endotracheal tube removal, ICU length of stay, and catheter-related adverse events were followed up and recorded for each patient within 1 week after the procedure.ResultsA total of 14 patients who received LTx at this center from August 2023 to November 2023 were included. All patients received anterolateral approaches, and 10 (71.4%) of them underwent bilateral LTx. The duration of catheter placement was 2 (2–3) days, and the Resting NRS during catheter placement was equal to or less than 4. A total of 11 patients (78.6%) were supported by extracorporeal membrane oxygenation (ECMO) in LTx, whereas 8 patients (57.1%) removed the tracheal tube on the first day after LTx. Intensive care unit (ICU) stay was 5 (3–6) days, with tracheal intubation retained for 1 (1–2) days, and only one patient was reintubated. The morphine equivalent dose (MED) in the first week after LTx was 11.95 mg, and no catheter-related adverse events were detected.LimitationsWe did not assess the sensory loss plane due to the retrospective design. In addition, differences in catheter placement time May lead to bias in pain assessment.ConclusionAlthough continuous SAPB May be a safe and effective fascial block technique for relieving acute pain after LTx, it should be confirmed by high-quality clinical studies.","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142266430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum: Regional disparities in the prevalence and correlated factors of myopia in children and adolescents in Gansu, China. 更正:中国甘肃省儿童青少年近视发病率及相关因素的地区差异。
IF 3.1 3区 医学
Frontiers in Medicine Pub Date : 2024-09-17 eCollection Date: 2024-01-01 DOI: 10.3389/fmed.2024.1487929
Jinyu Wang, Sheng Li, Shiqi He, Yali Feng, Pu Li
{"title":"Corrigendum: Regional disparities in the prevalence and correlated factors of myopia in children and adolescents in Gansu, China.","authors":"Jinyu Wang, Sheng Li, Shiqi He, Yali Feng, Pu Li","doi":"10.3389/fmed.2024.1487929","DOIUrl":"https://doi.org/10.3389/fmed.2024.1487929","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/fmed.2024.1375080.].</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142361396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Patients-oriented treatments for chronic inflammatory skin diseases. 社论:以患者为导向的慢性炎症性皮肤病治疗方法。
IF 3.1 3区 医学
Frontiers in Medicine Pub Date : 2024-09-17 eCollection Date: 2024-01-01 DOI: 10.3389/fmed.2024.1473753
Luca Mastorino, Simone Ribero, Martina Burlando, Pedro Mendes-Bastos
{"title":"Editorial: Patients-oriented treatments for chronic inflammatory skin diseases.","authors":"Luca Mastorino, Simone Ribero, Martina Burlando, Pedro Mendes-Bastos","doi":"10.3389/fmed.2024.1473753","DOIUrl":"10.3389/fmed.2024.1473753","url":null,"abstract":"","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11445658/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report: Recurrence of primary hepatic neuroendocrine tumors after resection of liver segments IV in 8 years follow-up. 病例报告:肝IV段切除术后原发性肝神经内分泌肿瘤复发,随访8年。
IF 3.1 3区 医学
Frontiers in Medicine Pub Date : 2024-09-16 eCollection Date: 2024-01-01 DOI: 10.3389/fmed.2024.1437650
Chunli Li, Li Bian, Guangtao Fan, Yilong Huang, Jiang Li, Bo He
{"title":"Case report: Recurrence of primary hepatic neuroendocrine tumors after resection of liver segments IV in 8 years follow-up.","authors":"Chunli Li, Li Bian, Guangtao Fan, Yilong Huang, Jiang Li, Bo He","doi":"10.3389/fmed.2024.1437650","DOIUrl":"10.3389/fmed.2024.1437650","url":null,"abstract":"<p><strong>Background: </strong>Primary hepatic neuroendocrine tumors (PHNETs) are an utterly rare entity. The diagnosis of PHNETs could legitimize when an extrahepatic primary NET must always be excluded. PHNETs can achieve a high survival rate after complete surgical resection, however, most patients still have an 18% risk of recurrence within 5 years after surgery. In our case, the recurrence occurred 8 years after the first hepatectomy, which is relatively rare in the current literature. Therefore, rigorous postoperative follow-up is necessary for early detection and timely treatment of recurrent PHNETs.</p><p><strong>Case information: </strong>We report a case of PHNET in a 24-year-old previously healthy female patient who relapsed 8 years after hepatectomy. This case focuses on the importance of diagnosis of primary and recurrent PHNETS in young patients, rare pathological types, and post-operative follow-up.</p><p><strong>Conclusion: </strong>This case report detailed the rare pathological morphology and characteristic immunohistochemical markers in our case for PHNETS, which enhanced the new understanding of the diagnosis of this entity. In addition, we also highlighted the variable duration of recurrence after treatment of PHNETs. The 8-year recurrent period in our case suggests the importance of regular examination in patients with PHNETs by following the doctor's instructions.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439660/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Network pharmacology and molecular docking approach to elucidate the mechanisms of safflower, phellodendron, scutellaria baicalensis, coptis, and gardenia in hand-foot syndrome. 通过网络药理学和分子对接方法阐明红花、黄柏、黄芩、黄连和栀子在手足综合征中的作用机制。
IF 3.1 3区 医学
Frontiers in Medicine Pub Date : 2024-09-16 eCollection Date: 2024-01-01 DOI: 10.3389/fmed.2024.1454776
Pengxing Li, Lizhu Chen, Jianhui Liu
{"title":"Network pharmacology and molecular docking approach to elucidate the mechanisms of safflower, phellodendron, scutellaria baicalensis, coptis, and gardenia in hand-foot syndrome.","authors":"Pengxing Li, Lizhu Chen, Jianhui Liu","doi":"10.3389/fmed.2024.1454776","DOIUrl":"10.3389/fmed.2024.1454776","url":null,"abstract":"<p><strong>Background: </strong>Safflower, phellodendron, scutellaria baicalensis, coptis, and gardenia (SPSCG) are medicinal plants with a wide range of anti-inflammatory and antioxidant effects. However, the related mechanism of SPSCG against hand-foot syndrome (HFS) has yet to be revealed.</p><p><strong>Objective: </strong>To investigate the mechanisms of SPSCG in the treatment of HFS using the Network Pharmacology.</p><p><strong>Methods: </strong>Active ingredients and targets of SPSCG for HFS were screened by the Chinese Medicine Systems Pharmacology (TCMSP) and Swiss Target Prediction databases. Potential therapeutic targets were collected from the GeneCards and OMIM databases. Subsequently, protein-protein interactions (PPI), Gene Ontology (GO) annotations, and pathways from the Kyoto Encyclopedia of Genes and Genomes (KEGG) were performed to investigate the potential mechanism of the SPSCG in HFS. Then, molecular docking and molecular dynamics simulations were performed to predict the binding interactions between the active compound and the core target. Finally, vitro experiments were used to verify the repair effect of key ingredients of SPSCG on cell damage caused by 5-Fluorouracil.</p><p><strong>Results: </strong>Quercetin, kaempferol, β-sitosterol, and stigmasterol were identified as the major active components of SPSCG. GO analysis showed a total of 1,127 biological processes, 42 terms cellular components, and 57 molecular functions. KEGG analysis showed that the MAPK, TNF, and IL-17 signaling pathways were significantly enriched. The PPI analysis discovered that EGFR, CASP3, AKT1, CCND1, and CTNNB1 shared the highest centrality among all target genes. The experimental results confirmed that these SPSCG active ingredients could treat HFS by reducing inflammation reaction and promoting cell damage repair.</p><p><strong>Conclusion: </strong>SPSCG may alleviate HFS by exerting antioxidative effects and suppressing inflammatory responses.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142361398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urolithin A alleviates cell senescence by inhibiting ferroptosis and enhances corneal epithelial wound healing. 尿囊素 A 可通过抑制铁变态反应缓解细胞衰老,并促进角膜上皮伤口愈合。
IF 3.1 3区 医学
Frontiers in Medicine Pub Date : 2024-09-16 eCollection Date: 2024-01-01 DOI: 10.3389/fmed.2024.1441196
Xiao-Xiao Guo, Xue-Jiao Chang, Qi Pu, Ao-Ling Li, Jing Li, Xin-Yu Li
{"title":"Urolithin A alleviates cell senescence by inhibiting ferroptosis and enhances corneal epithelial wound healing.","authors":"Xiao-Xiao Guo, Xue-Jiao Chang, Qi Pu, Ao-Ling Li, Jing Li, Xin-Yu Li","doi":"10.3389/fmed.2024.1441196","DOIUrl":"10.3389/fmed.2024.1441196","url":null,"abstract":"<p><strong>Purpose: </strong>To analyze the therapeutic effect and mechanism of Urolithin A (UA) on delayed corneal epithelial wound healing.</p><p><strong>Methods: </strong>The C57BL/6 mice were continuously exposed to hyperosmotic stress (HS) for 7 days followed by the removal of central corneal epithelium to establish a delayed corneal epithelial wound healing model <i>in vivo</i>. <i>In vitro</i>, the human corneal epithelial cell line (HCE-T) was also incubated under HS. UA was administered <i>in vivo</i> and <i>in vitro</i> to study its effects on corneal epithelial cells. Senescence-associated β-galactosidase (SA-β-gal) staining was performed to detect the level of cell senescence. Transcriptome sequencing (RNA-seq) was conducted to elucidate the molecular mechanism underlying the effect of UA on corneal epithelial repair. Additionally, the expression of senescence-related and ferroptosis-related genes and the levels of lipid peroxides (LPO) and malondialdehyde (MDA) were measured.</p><p><strong>Results: </strong>Hyperosmotic stress (HS) significantly increased the proportion of SA-β-gal staining positive cells in corneal epithelial cells and upregulated the expression of p16 and p21 (<i>p</i> < 0.0001). Topical application of UA decreased the accumulation of senescent cells in corneal epithelial wounds and promoted epithelial wound healing. The results of RNA-seq of HS-induced corneal epithelial cells showed that the ferroptosis pathway was significantly dysregulated. Further investigation revealed that UA decreased the level of oxidative stress in HCE-T cells, including the levels of LPO and MDA (<i>p</i> < 0.05). Inhibition of ferroptosis significantly prevented cellular senescence in HS-induced HCE-T cells.</p><p><strong>Conclusion: </strong>In this study, UA promoted HS-induced delayed epithelial wound healing by reducing the senescence of corneal epithelial cells through the inhibition of ferroptosis.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cross-talk between macrophages and gut microbiota in inflammatory bowel disease: a dynamic interplay influencing pathogenesis and therapy. 炎症性肠病中巨噬细胞与肠道微生物群之间的交叉对话:影响发病机制和治疗的动态相互作用。
IF 3.1 3区 医学
Frontiers in Medicine Pub Date : 2024-09-16 eCollection Date: 2024-01-01 DOI: 10.3389/fmed.2024.1457218
Shiyang Ning, Zhe Zhang, Chuan Zhou, Binbin Wang, Zhanju Liu, Baisui Feng
{"title":"Cross-talk between macrophages and gut microbiota in inflammatory bowel disease: a dynamic interplay influencing pathogenesis and therapy.","authors":"Shiyang Ning, Zhe Zhang, Chuan Zhou, Binbin Wang, Zhanju Liu, Baisui Feng","doi":"10.3389/fmed.2024.1457218","DOIUrl":"10.3389/fmed.2024.1457218","url":null,"abstract":"<p><p>Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), is a group of chronic immune-mediated gastrointestinal disorders. The etiology of IBD is multifactorial, involving genetic susceptibility, environmental factors, and a complex interplay between the gut microbiota and the host's immune system. Intestinal resident macrophages play an important role in the pathogenesis and progress of IBD, as well as in maintaining intestinal homeostasis and facilitating tissue repair. This review delves into the intricate relationship between intestinal macrophages and gut microbiota, highlighting their pivotal roles in IBD pathogenesis. We discuss the impact of macrophage dysregulation and the consequent polarization of different phenotypes on intestinal inflammation. Furthermore, we explore the compositional and functional alterations in gut microbiota associated with IBD, including the emerging significance of fungal and viral components. This review also examines the effects of current therapeutic strategies, such as 5-aminosalicylic acid (5-ASA), antibiotics, steroids, immunomodulators, and biologics, on gut microbiota and macrophage function. We underscore the potential of fecal microbiota transplantation (FMT) and probiotics as innovative approaches to modulate the gut microbiome in IBD. The aim is to provide insights into the development of novel therapies targeting the gut microbiota and macrophages to improve IBD management.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443506/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142361397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信